Sterile Cord Blood Collection Unit (msc123d) Injection, Solution
NDC Package 14498-005-01
Package Information
Sterile Cord Blood Collection Unit (msc123d) (anticoagulant citrate phosphate dextrose) injection is mSC123D - For collection of up to 210 mL of umbilical cord blood. This formulation utilizes a injection, solution delivery system. Marketed by Maco Productions, this product is identified by NDC 14498-005 and is authorized under FDA application BN125552.
Identification & Billing
Clinical Specifications
- Acidifying Activity - [MoA] (Mechanism of Action)
- Acidifying Activity - [MoA] (Mechanism of Action)
- Anti-coagulant - [EPC] (Established Pharmacologic Class)
- Calcium Chelating Activity - [MoA] (Mechanism of Action)
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Decreased Coagulation Factor Activity - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 14498 - Maco Productions
- 14498-005 - Sterile Cord Blood Collection Unit (msc123d)
- 14498-005-01 - 1 KIT in 1 KIT / 35 mL in 1 KIT
- 14498-005 - Sterile Cord Blood Collection Unit (msc123d)
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 14498-005-01 identifies a specific commercial package of 1 kit in 1 kit / 35 ml in 1 kit of Sterile Cord Blood Collection Unit (msc123d), a human prescription drug labeled by Maco Productions. This injection, solution is formulated for intravenous use and contains citric acid monohydrate; dextrose monohydrate; sodium citrate; sodium phosphate, monobasic, dihydrate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Maco Productions on October 02, 2020. The current certification is valid through December 31, 2026.
How is this Maco Productions product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 14498000501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.